-
Mashup Score: 0A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota - 9 month(s) ago
The polyphenol castalagin acts as a prebiotic and exerts antitumor activity as well as potentiates anti–PD-1 immune efficacy through a beneficial shift in microbiome composition.
Source: aacrjournals.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
Cabozantinib plus atezolizumab showed promising antitumour activity in patients with metastatic castration-resistant prostate cancer after novel hormonal therapy with an acceptable safety profile, supporting further evaluation of this combination.
Source: www.thelancet.comCategories: Hem/Oncs, Latest HeadlinesTweet-
@neerajaiims @ASCO @OncoAlert @urotoday @PCF_Science @DrChoueiri @NeliMUlrich @WilliamOhMD @AzadOncology @shilpaonc @PGrivasMDPhD @apolo_andrea @VivekSubbiah @huntsmancancer @amerseburger It was a joy to work on #COSMIC021 w @neerajaiims (see @TheLancetOncol paper here: https://t.co/ohVXJ6xsca); awesome to see his key insights from that trial bear fruit in the design of #CONTACT02. Could not agree w him more that our pts w #prostatecancer need add’l non-chemo… https://t.co/AlsnmNmHk3 https://t.co/DpS3xxqP9U
-
-
Mashup Score: 3
Fifteen years ago, after the death of his favorite uncle, Steven Rosen committed his grief to paper. Grief took the shape of a poem—“Uncle Lenny.” It was Rosen’s first. Over ensuing years, Rosen, an expert in hematologic malignancies who has served as director of the cancer centers at City of Hope and Northwestern University, has […]
Source: cancerletter.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
In this episode of ASCO Educational podcasts, we’ll explore how we interpret and integrate recently reported clinical research into practice. Part One involved a 72-year old man with high-risk, localized prostate cancer progressing to hormone-sensitive metastatic disease. Today’s scenario focuses on de novo metastatic prostate cancer. Our guests are Dr. Kriti Mittal (UMass Chan Medical School) and Dr. Jorge Garcia (Case Western Reserve University School of Medicine). Together they present the patient scenario (1:13), going beyond the one-size-fits-all approach (4:54), and thinking about the patient as a whole (13:39). Speaker Disclosures Dr. Kriti Mittal: Honoraria – IntrinsiQ; Targeted Oncology; Medpage; Aptitude Health; Cardinal Health Consulting or Advisory Role – Bayer; Aveo; Dendreon; Myovant; Fletcher; Curio Science; AVEO; Janssen; Dedham Group Research Funding – Pfizer Dr. Jorge Garcia: Honoraria – MJH Associates: Aptitude Health; Janssen Consulting or Advisor – Eisai; Targe
Source: auwpod.libsyn.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4A Work in Progress - 9 month(s) ago
Intellectual humility is the mark of an excellent physician
Source: medicine.yale.eduCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 2Faculty Position: Gastrointestinal Oncology Service - New York City and New Jersey - 10 month(s) ago
The MSK Gastrointestinal Oncology Service is seeking a full-time faculty member at the Assistant Attending level for a clinical investigator position.
Source: careercenter.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5The Uromigos Merch Store - 11 month(s) ago
The Uromigos
Source: The UromigosCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Products - 12 month(s) ago
The Uromigos
Source: The UromigosCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 10AKCI - 1 year(s) ago
Our vision is to foster the development and commitment of early career kidney cancer investigators through provision of the raw materials and structured mentorship for focused, sustainable and ultimately independent success. …
Source: AKCICategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Interactions between programmed death ligand 2 (PD-L2) and its binding partner RGMb are downregulated by the gut microbiota, a mechanism that may be exploited to enhance the efficacy of PD-1-based cancer immunotherapies.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet
Wow! We are soon to begin a trial of camu camu w IO in #kidneycancer, inspired by @BertrandRouty’s excellent paper in @CD_AACR, at @cityofhope. The study will be led by @ReginaBarCar @ChawlaNeal. See Routy’s CD article here: https://t.co/2TQuKDmT1q https://t.co/bTmhCCZ6Pk https://t.co/a2b9Gxnh2n